Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its audited results for the year ended 31 December 2025. The Group reported revenue growth of 7% (6% in constant currency) to $3.349 billion, compared to $3.127 billion in 2024 with growth in all three geographies, North America, MENA, and Europe. Said Darwazah, […] The post Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes appeared first on Web-Release.
Breaking News:
- 48 Hours, Your Way at Vida Hotels and Resorts
- LG ELECTRONICS INVITES THE WORLD TO EXPERIENCE “INNOVATION IN TUNE WITH YOU” AT IFA 2026
- LG ELECTRONICS EARNS NVIDIA AI FACTORY VALIDATION FOR ITS 600KW COOLANT DISTRIBUTION UNIT
- See Out the Summer on a High Note at Al Habtoor Polo Resort with a Line-Up of Dining, Entertainment, and Staycation Experiences
- GFH REPORTS AN INCREASE OF 13.33% IN NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS FOR THE FIRST HALF OF 2026 TOTALING US$ 76.20 MILLION
- PUBG MOBILE Partners with Do Big Studios to Bring Brainrot Royale to World of Wonder
- Business Lunch at Origins – Vida Dubai Mall
- Tech Mahindra Unveils Sonic Identity, Marking the Next Phase of Its Brand Transformation
Friday, August 14
